Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report

2.7.2 Lipid Therapy Status

Data on the breakdown of fasting lipids in regards to lipid therapy status

Page last updated: December 2011

Table 20 provides a breakdown of the fasting Lipids data in regards to Lipid Therapy Status [as does Table 13 [page 20] for Blood Pressure and anti-hypertensive therapy]. Overall 60.0% of Adult Form individuals were stated to be on anti-Lipid Therapy. There is a difference for Total and LDL Cholesterol & for Triglycerides (lower in those not stated to be on Rx), [but minimal difference for HDL Cholesterol] between those where Lipid Therapy [Rx] is Yes versus No, compared to all data. See Frequency Tables for n= & range data.
See Tables on Pages 171-184 of Appendix 5 for Individual Anti-Lipid Therapy Data.

Table 20 – Fasting Lipids and Lipid Therapy Status (Mean SD)

Fasting Lipids
All Sites
Adult Forms
Paediatric Forms
n = 4629
n = 4629
n = 0
Fasting Cholesterol
4.3 1.1
Fasting Cholesterol - Lipid Rx = Yes
4.1 1.1
Fasting Cholesterol - Lipid Rx = No
4.7 1.1
Fasting HDL Cholesterol
1.2 0.4
Fasting HDL Cholesterol - Lipid Rx = Yes
1.2 0.4
Fasting HDL Cholesterol - Lipid Rx = No
1.3 0.4
Fasting Triglyceride
1.8 1.6
Fasting Triglyceride - Lipid Rx = Yes
1.9 1.5
Fasting Triglyceride - Lipid Rx = No
1.6 1.9
Fasting LDL Cholesterol
2.2 0.9
Fasting LDL Cholesterol - Lipid Rx = Yes
2.1 0.8
Fasting LDL Cholesterol - Lipid Rx = No
2.7 0.9

Document download

This publication is available as a downloadable document.

Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)